Detailed Information on Publication Record
2023
N-Indolyl diiron vinyliminium complexes exhibit antiproliferative effects in cancer cells associated with disruption of mitochondrial homeostasis, ROS scavenging, and antioxidant activity
BRESCIANI, Giulio, Jakub ČERVINKA, Hana KOSTRHUNOVÁ, Lorenzo BIANCALANA, Marco BORTOLUZZI et. al.Basic information
Original name
N-Indolyl diiron vinyliminium complexes exhibit antiproliferative effects in cancer cells associated with disruption of mitochondrial homeostasis, ROS scavenging, and antioxidant activity
Authors
BRESCIANI, Giulio (380 Italy), Jakub ČERVINKA (203 Czech Republic, belonging to the institution), Hana KOSTRHUNOVÁ (203 Czech Republic), Lorenzo BIANCALANA (380 Italy), Marco BORTOLUZZI (380 Italy), Guido PAMPALONI (380 Italy), Vojtěch NOVOHRADSKÝ (203 Czech Republic), Viktor BRABEC (203 Czech Republic), Fabio MARCHETTI (380 Italy) and Jana KAŠPÁRKOVÁ (203 Czech Republic)
Edition
Chemico-Biological Interactions, Elsevier B.V, 2023, 0009-2797
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10608 Biochemistry and molecular biology
Country of publisher
Ireland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 5.100 in 2022
RIV identification code
RIV/00216224:14310/23:00132046
Organization unit
Faculty of Science
UT WoS
001094243700001
Keywords in English
Diiron complexes; Indole; Anticancer; Mitochondria; ROS; Antioxidant
Tags
Tags
International impact, Reviewed
Změněno: 5/12/2023 11:30, Mgr. Marie Šípková, DiS.
Abstract
V originále
The indole scaffold has been established as a key organic moiety for developing new drugs; on the other hand, a range of diiron bis-cyclopentadienyl complexes have recently emerged for their promising anticancer potential. Here, we report the synthesis of novel diiron complexes with an indole-functionalized vinyliminium ligand (2–5) and an indole-lacking analogue for comparative purposes (6), which were characterized by analytical and spectroscopic techniques. Complexes 2–6 are substantially stable in DMSO‑d6 and DMEM-d solutions at 37 °C (8% average degradation after 48 h) and display a balanced hydrophilic/lipophilic behaviour (LogPow values in the range −0.32 to 0.47), associated with appreciable water solubility. The complexes display selective antiproliferative potency towards several cancer cells in monolayer cultures, mainly in the low micromolar range, with reduced toxicity towards noncancerous epithelial cells. Thus, the cytotoxicity of the complexes is comparable to or better than clinically used metallopharmaceutical cisplatin. Comparing the antiproliferative activity obtained for complexes containing different ligands, we confirmed the importance of the indolyl group in the mechanism of antiproliferative activity of these complexes. Cell-based mechanistic studies suggest that the investigated diiron vinyliminium complexes (DVCs) show cytostatic rather than cytotoxic effects and subsequently induce a population of cells to undergo apoptosis. Furthermore, the molecular mechanism of action involves interactions with mitochondrial DNA and proteins, the reactive oxygen species (ROS)-scavenging properties and antioxidant activity of these complexes in cancer cells. This study highlights the importance of DVCs to their cancer cell activity and reinforces their prospective therapeutic potential as anticancer agents.